|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Marketable investment securities | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventory, net | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Marketable securities held in trust account | ||||||||||||||||||||
| PIPE exchange consideration | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Capitalized software development costs, net | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accrued expenses - related party | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Taxes payable | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Customer deposits | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| PIPE loan payable, net | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total pIPE loan payable, net | ||||||||||||||||||||
| Notes payable, current portion | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Notes payable, current portion | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Line of credit, bank | ||||||||||||||||||||
| Margin line of credit account | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Notes payable assumed in Merger | ||||||||||||||||||||
| Dividend notes payable | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Accrued and other current liabilities | ||||||||||||||||||||
| Accrued and other current liabilities - assumed in Merger | ||||||||||||||||||||
| Lease liability, current portion | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Non-current liabilities: | ||||||||||||||||||||
| Deferred underwriting commissions | ||||||||||||||||||||
| Note payables, net of current portion | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Notes payable assumed in the Merger | ||||||||||||||||||||
| Note payables, net of current portion | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total note payables, net of current portion | ||||||||||||||||||||
| PIPE loan payable, net | ||||||||||||||||||||
| Dividend notes payable | ||||||||||||||||||||
| Gross sales royalty payable | ||||||||||||||||||||
| Lease liability, net of current portion | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common stock subject to possible redemption, 574,764 shares at $11.37 per share and 830,210 shares at $10.83 per share as of December 31, 2023 and March 31, 2023, respectively | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Common stock, value | ||||||||||||||||||||
| Series A Common Stock | ||||||||||||||||||||
| Series B Common Stock | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Common Class B | ||||||||||||||||||||
| Treasury stock at cost, 9 shares of common stock held, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
